Patriot Financial Group Insurance Agency’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-5,300	Closed	-$153K	–	1098
2022 Q2	$153K	Hold	5,300	–	–	0.03%	442
2022 Q1	$183K	Sell	5,300 -36	-0.7%	-$1.27K	0.03%	428
2021 Q4	$234K	Sell	5,336 -96	-2%	-$4.54K	0.04%	414
2021 Q3	$275K	Hold	5,432	–	–	0.05%	363
2021 Q2	$283K	Buy	5,432 +5,245	+2,805%	+$246K	0.05%	348
2021 Q1	$9K	Buy	187 +55	+42%	+$2.69K	﹤0.01%	1380
2020 Q4	$6K	Sell	132 -75	-36%	-$3.24K	﹤0.01%	1376
2020 Q3	$8K	Sell	207 -213	-51%	-$8.19K	﹤0.01%	1091
2020 Q2	$16K	Buy	+420	New	+$14.2K	0.01%	813

Other funds holding IDNA

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Patriot Financial Group Insurance Agency's IDNA Position: Q3 2022 in Review

Patriot Financial Group Insurance Agency sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q3 2022, closing a stake of 5,300 shares — an estimated $153K sold.

Patriot Financial Group Insurance Agency first reported a position in IDNA in Q2 2020 and held it in 9 quarters. The position peaked at $283K in Q2 2021. 67 funds tracked by Wall St. Rank hold IDNA as of Q3 2022.

Patriot Financial Group Insurance Agency reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q3 2022 after selling out during the quarter.
Patriot Financial Group Insurance Agency sold 5,300 iShares Genomics Immunology and Healthcare ETF shares in Q3 2022, an estimated $153K.
Patriot Financial Group Insurance Agency first reported a position in iShares Genomics Immunology and Healthcare ETF in Q2 2020 and held it in 9 quarters.
Patriot Financial Group Insurance Agency's iShares Genomics Immunology and Healthcare ETF position peaked at $283K in Q2 2021.
67 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q3 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.